NCT04680988 2025-08-05
A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
Clinical Trials
6 trialsNCT04346381 2023-09-18
Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT02390947 2020-12-22
FACT
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed
NCT01392235 2019-01-22
Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT01829841 2018-05-03
A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT01762293 2018-04-18
A Study of Famitinib in Patients With Advanced Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed